首页> 外文OA文献 >Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial

【2h】

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial

机译：静脉内免疫球蛋白与利妥昔单抗与rituximab在儿童发病类固醇依赖性和经常复发性肾病综合征的疗效和安全性：多期一组随机对照试验的方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Julien Hogan; Aubriana Perez; Anne-Laure Sellier-Leclerc; Isabelle Vrillon; Francoise Broux; Francois Nobili; Jerome Harambat; Lucie Bessenay; V Audard; Camille Faudeux; Denis Morin; Christine Pietrement; Stephanie Tellier; Djamal Djeddi; Philippe Eckart; Annie Lahoche; G Roussey-Kesler; Tim Ulinski; Olivia Boyer; Emmanuelle Plaisier; Sylvie Cloarec; Anne Jolivot; Vincent Guigonis; Sophie Guilmin-Crepon; Veronique Baudouin; Claire Dossier; Georges Deschênes;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial [J] . Kazumoto lijima, Mayumi Sako, Kai Nozu, The Lancet . 2014,第9950期

机译：利妥昔单抗治疗儿童期，复杂，经常复发的肾病综合征或类固醇依赖型肾病综合征：一项多中心，双盲，随机，安慰剂对照试验
2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07) [J] . Tomoko Horinouchi, Mayumi Sako, Koichi Nakanishi, BMC Nephrology . 2018,第1期

机译：研究方案：利妥昔单抗治疗后的霉酚酸酯作为儿童期发作的，复杂的，经常复发的肾病综合征或类固醇依赖性肾病综合征的维持治疗：一项多中心，双盲，随机，安慰剂对照试验（JSKDC07）
3. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial) [J] . China Nagano, Mayumi Sako, Koichi Kamei, BMC Nephrology . 2019,第1期

机译：研究方案：利妥昔单抗的多中心双盲，随机，安慰剂对照试验，用于治疗儿童期早期早期并发的频繁复发或类固醇依赖性肾病综合征（JSKDC10试验）
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial [O] . Julien Hogan, Aubriana Perez, Anne-Laure Sellier-Leclerc, 2020

机译：静脉内免疫球蛋白与利妥昔单抗与rituximab在儿童发病类固醇依赖性和经常复发性肾病综合征的疗效和安全性：多期一组随机对照试验的方案
6. POS-457 EFFICACY AND SAFETY OF RITUXIMAB VERSUS TACROLIMUS IN FREQUENTLY RELAPSING NEPHROTIC SYNDROME: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL [O] . G. Mathew, A. Sinha, N. Grewal, 2021

机译：Rituximab与Tacrolimus经常复发肾病综合征的POS-457疗效和安全性：一个开放标签随机对照试验

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅